Investigational New Drug
|Category|| : ||Governmental » Rules & Regulations
|Country/Region|| : ||United States
|Popularity|| : ||
What does IND mean?
The United States Food and Drug Administration’s Investigational New Drug (IND) program is the means by which a pharmaceutical company obtains permission to ship an experimental drug across state lines (usually to clinical investigators) before a marketing application for the drug has been approved. The FDA reviews the IND application for safety to assure that research subjects will not be subjected to unreasonable risk.